Bay FC Mom’s Clinic, Presented by Sutter Health - Bay FC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Bay FC and Sutter Health are teaming up to host a free Mom’s Clinic on Saturday, Nov. 7, at Presentation High School in San Jose. The fun and active clinic will be led by coaches from the Women’s Coaching Alliance, a global network based in the Bay Area that supports the training and empowerment of women coaches.
Attendees will learn the basics of soccer, boost their skills, and build the confidence to jump into the game with their kids anytime, anywhere. No experience is necessary to attend.
This article is an excerpt. To read the full content, visit the original source. Bay FC
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!